{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    8,
    29
  ],
  "modelUsed": "gemini-3-flash",
  "advanced": {
    "studyAmendments": [
      {
        "id": "amend_1",
        "number": "a",
        "name": "Amendment a",
        "scope": {
          "id": "984199fc-1c1e-49b2-8aed-3f835f45958b",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "9f57a4e6-8eac-4327-8c01-03a15e1da2e6",
          "code": {
            "id": "955c8ef5-8bd3-4b25-b5fa-835da14e8bdd",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "2eb92320-a03e-417e-b7c1-ef80db57cb4e",
            "type": {
              "id": "aa4d3b8f-348e-4209-86e4-ead8986154cc",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "Amendment (a) was electronically signed and approved by Lilly on 28 Sep 2018.",
        "effectiveDate": "2018-09-28",
        "reasonIds": [
          "ar_1_1"
        ],
        "previousVersion": "Original Protocol",
        "newVersion": "a"
      },
      {
        "id": "amend_2",
        "number": "b",
        "name": "Amendment b",
        "scope": {
          "id": "c31d3f7f-7ddb-48f0-8e5f-ccacae3589c0",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "03ed2644-b85f-47c9-93c0-902b5a863da9",
          "code": {
            "id": "48893c20-c626-4f7d-85fd-acca232c6de5",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "9eabe8c3-3116-4a55-a62c-07864edeb7cd",
            "type": {
              "id": "bd470925-d681-47cd-bfdf-5a008ad3997a",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The main reason for preparation of this amendment was to incorporate changes to study procedures due to the COVID-19 pandemic, as detailed in Appendix 8, and to update the protocol for the SURPASS-4 study.",
        "effectiveDate": "2020-07-10",
        "reasonIds": [
          "ar_2_1",
          "ar_2_2"
        ],
        "previousVersion": "a",
        "newVersion": "b"
      }
    ],
    "amendmentReasons": [
      {
        "id": "ar_1_1",
        "code": "ADMINISTRATIVE",
        "description": "Administrative",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_1",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_2",
        "code": "REGULATORY",
        "description": "Regulatory",
        "instanceType": "AmendmentReason"
      }
    ],
    "countries": [],
    "studySites": [],
    "summary": {
      "amendmentCount": 2,
      "countryCount": 0,
      "siteCount": 0
    },
    "geographicScope": {
      "id": "geo_1",
      "name": "Study Geographic Scope",
      "scopeType": "Global",
      "instanceType": "GeographicScope"
    }
  },
  "rawResponse": {
    "amendments": [
      {
        "number": "Original Protocol",
        "effectiveDate": "2018-07-18",
        "summary": "Initial release of the protocol for the SURPASS-4 study evaluating the efficacy and safety of LY3298176 once weekly versus insulin glargine in patients with type 2 diabetes and increased cardiovascular risk.",
        "previousVersion": null,
        "newVersion": "Original",
        "reasons": [
          "Scientific"
        ]
      },
      {
        "number": "a",
        "effectiveDate": "2018-09-28",
        "summary": "Amendment (a) was electronically signed and approved by Lilly on 28 Sep 2018.",
        "previousVersion": "Original Protocol",
        "newVersion": "a",
        "reasons": [
          "Administrative"
        ]
      },
      {
        "number": "b",
        "effectiveDate": "2020-07-10",
        "summary": "The main reason for preparation of this amendment was to incorporate changes to study procedures due to the COVID-19 pandemic, as detailed in Appendix 8, and to update the protocol for the SURPASS-4 study.",
        "previousVersion": "a",
        "newVersion": "b",
        "reasons": [
          "Operational",
          "Regulatory"
        ]
      }
    ],
    "geographicScope": {
      "type": "Global",
      "countries": [],
      "regions": [],
      "plannedSites": null
    },
    "sites": []
  }
}